, Tracking Stock Market Picks
Enter Symbol:
Alcon Inc (ACL) [hlAlert]

up 99.77 %

Alcon Inc (ACL) rated Buy by FTN Midwest

Posted on: Wednesday,  Jan 21, 2009  9:25 AM ET by FTN Midwest

FTN Midwest rated Buy Alcon Inc (NYSE: ACL) on 01/21/2009, when the stock price was $84.09. Since
then, Alcon Inc has gained 99.77% as of 04/08/2011's recent price of $167.99.
If you would have followed this FTN Midwest's recommendation on ACL, you would have gained 99.77% of your investment in 807 days.

Alcon, Inc. (Alcon) is a research and development driven, global medical specialty company focused on eye care. The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye. Alcon manages its business through two segments: Alcon United States and Alcon International. Its portfolio spans three key ophthalmic categories: pharmaceutical, surgical and consumer eye care products. In its pharmaceutical category Alcon develops, manufactures and markets a range of prescription ophthalmic pharmaceutical products. Alcon offers a range of surgical equipment, single-use and disposable products. The Company markets contact lens care products, artificial tears and ocular vitamins, in its consumer eye care products category. In July 2008, Novartis AG acquired a 25% stake in Alcon from Nestle SA.

Having access to accurate and timely information is essential for success in today's marketplace. At FTN Midwest, our focus is on providing thorough and objective research to our clients, empowering them to make the well-informed and educated decisions that help enhance their investment process. Our highly experienced team of analytical experts research, examine, and evaluate businesses in several markets, including consumer, health care, business and technology services, and financial service sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/21/2009 9:25 AM Buy
as of 12/31/2009
1 Week up  1.61 %
1 Month up  10.11 %
3 Months up  17.42 %
1 YTD up  93.64 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy